Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Exploring Carissa spinarum as a therapeutic candidate: metabolite profiling and antimicrobial evaluation.

Created on 12 Aug 2026

Authors

Laiba Ali, Shahid Nawaz, Sikandar Ali, Asad Ur Rehman, Iram Liaqat, Shaukat Ali, Muhammad Nauman Aftab

Published in

Natural product research. Pages 1-8. Aug 11, 2026. Epub Aug 11, 2026.

Abstract

Carissa spinarum L. is traditionally valued for its medicinal properties, yet its bioactive potential remains insufficiently explored. In this study, stem and leaf extracts were evaluated for their total phenolic content (TPC), metabolite composition, and biological activities. TPC values were 87.13 and 89.90 mg GAE at concentrations of 217.83 mg/mL and 224.78 mg/mL for stem and leaf extracts, respectively. 1H-NMR analysis revealed several tentative bioactive metabolites including syringic acid, catechin, hiravanone, quinic acid, betulinic acid, and linoleic acid. Antibacterial activity tested against Escherichia coli, Staphylococcus aureus, Bacillus subtilis and MRSA showed strong inhibition of all pathogens except B. subtilis. Anticancer activity on HeLa cells and antioxidant evaluation using DPPH confirmed higher efficacy of the stem extract compared to the leaf extract. Overall, C. spinarum demonstrates promising antibacterial, anticancer, and antioxidant properties, supporting its potential as a source of natural therapeutic agents.

PMID:
42579789
Bibliographic data and abstract were imported from PubMed on 12 Aug 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 11
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement